Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond (Q36407449)

14 August 2017

1 reference

title

Treatment of gastric mucosa-associated lymphoid tissue lymphoma: Helicobacter pylori eradication and beyond (English)

1 reference

gastric mucosa-associated lymphoid tissue lymphoma

14 August 2017

0 references

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

Carlos Montalban

1

1 reference

PubMed ID

16503853

14 August 2017

Francesca Norman

series ordinal

2

1 reference

14 August 2017

1 March 2006

1 reference

Expert Review of Anticancer Therapy

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

3

1 reference

14 August 2017

361-371

1 reference

Gastric MALT lymphoma: from concept to cure

14 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Incidence of gastric B-cell lymphomas: a population-based study in Germany

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Molecular pathogenesis of mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated in multiple tumor types

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Helicobacter pylori infection and gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Additional neoplasms and HCV infection in low-grade lymphoma of MALT type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Histological and immunological parameters to predict treatment outcome of Helicobacter pylori eradication in low-grade gastric MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

High incidence of t(11;18)(q21;q21) in Helicobacter pylori-negative gastric MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Interobserver variation in the histopathological assessment of malt/malt lymphoma: towards a consensus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Proposal for a new histological grading system for post-treatment evaluation of gastric MALT lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach: results of a controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Treatment results in localized primary gastric lymphoma: data of patients registered within the German multicenter study (GIT NHL 02/96).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) with mitoxantrone, chlorambucil and prednisone (MCP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Fludarabine-containing chemotherapy as frontline treatment of nongastrointestinal mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

The role of surgery in primary gastric lymphoma: results of a controlled clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) for treatment of early-stage gastric diffuse large B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.6.3.361

21 January 2018

Identifiers

DOI

10.1586/14737140.6.3.361

1 reference

14 August 2017

1 reference

PubMed ID

16503853